Cargando…

Dendritic cells provide a therapeutic target for synthetic small molecule analogues of the parasitic worm product, ES-62

ES-62, a glycoprotein secreted by the parasitic filarial nematode Acanthocheilonema viteae, subverts host immune responses towards anti-inflammatory phenotypes by virtue of covalently attached phosphorylcholine (PC). The PC dictates that ES-62 exhibits protection in murine models of inflammatory dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lumb, Felicity E., Doonan, James, Bell, Kara S., Pineda, Miguel A., Corbet, Marlene, Suckling, Colin J., Harnett, Margaret M., Harnett, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431997/ https://www.ncbi.nlm.nih.gov/pubmed/28490801 http://dx.doi.org/10.1038/s41598-017-01651-1

Ejemplares similares

Protection Against Arthritis by the Parasitic Worm Product ES-62, and Its Drug-Like Small Molecule Analogues, Is Associated With Inhibition of Osteoclastogenesis
por: Doonan, James, et al.
Publicado: (2018)

Suppression of inflammatory arthritis by the parasitic worm product ES-62 is associated with epigenetic changes in synovial fibroblasts
por: Corbet, Marlene, et al.
Publicado: (2021)

Development of Acanthocheilonema viteae in Meriones shawi: Absence of microfilariae and production of active ES‐62
por: Lumb, Felicity E., et al.
Publicado: (2020)

The parasitic worm product ES-62 protects the osteoimmunology axis in a mouse model of obesity-accelerated ageing
por: Harnett, Margaret M., et al.
Publicado: (2022)

The parasitic worm product ES-62 normalises the gut microbiota bone marrow axis in inflammatory arthritis
por: Doonan, James, et al.
Publicado: (2019)

Drug-like analogues of the parasitic worm-derived immunomodulator ES-62 are therapeutic in the MRL/Lpr model of systemic lupus erythematosus
por: Rodgers, D T, et al.
Publicado: (2015)

Site-specific glycoproteomic characterization of ES-62: The major secreted product of the parasitic worm Acanthocheilonema viteae
por: North, Simon J, et al.
Publicado: (2019)

Failure of the Anti-Inflammatory Parasitic Worm Product ES-62 to Provide Protection in Mouse Models of Type I Diabetes, Multiple Sclerosis, and Inflammatory Bowel Disease
por: Doonan, James, et al.
Publicado: (2018)

Small Molecule Analogues of the parasitic worm product ES-62 interact with the TIR domain of MyD88 to inhibit pro-inflammatory signalling
por: Suckling, Colin J., et al.
Publicado: (2018)

Testing small molecule analogues of the Acanthocheilonema viteae immunomodulator ES‐62 against clinically relevant allergens
por: Janicova, L., et al.
Publicado: (2016)

The parasitic worm product ES-62 promotes health- and life-span in a high calorie diet-accelerated mouse model of ageing
por: Crowe, Jenny, et al.
Publicado: (2020)

Designing Anti-inflammatory Drugs from Parasitic Worms: A Synthetic Small Molecule Analogue of the Acanthocheilonema viteae Product ES-62 Prevents Development of Collagen-Induced Arthritis
por: Al-Riyami, Lamyaa, et al.
Publicado: (2013)

Prophylactic and therapeutic treatment with a synthetic analogue of a parasitic worm product prevents experimental arthritis and inhibits IL-1β production via NRF2-mediated counter-regulation of the inflammasome
por: Rzepecka, Justyna, et al.
Publicado: (2015)

The role of individual protein kinase C isoforms in mouse mast cell function and their targeting by the immunomodulatory parasitic worm product, ES-62
por: Bell, Kara S., et al.
Publicado: (2015)

The parasitic worm-derived immunomodulator, ES-62 and its drug-like small molecule analogues exhibit therapeutic potential in a model of chronic asthma
por: Coltherd, J. C., et al.
Publicado: (2016)

The Parasitic Worm Product ES-62 Targets Myeloid Differentiation Factor 88–Dependent Effector Mechanisms to Suppress Antinuclear Antibody Production and Proteinuria in MRL/lpr Mice
por: Rodgers, David T, et al.
Publicado: (2015)

Protective effect of small molecule analogues of the Acanthocheilonema viteae secreted product ES-62 on oxazolone-induced ear inflammation
por: Al-Riyami, Lamyaa, et al.
Publicado: (2015)

Small molecule analogues of the immunomodulatory parasitic helminth product ES-62 have anti-allergy properties
por: Rzepecka, Justyna, et al.
Publicado: (2014)

IL-33/ST2 signalling and crosstalk with FcεRI and TLR4 is targeted by the parasitic worm product, ES-62
por: Ball, Dimity H., et al.
Publicado: (2018)

Protection against collagen-induced arthritis in mice afforded by the parasitic worm product, ES-62, is associated with restoration of the levels of interleukin-10-producing B cells and reduced plasma cell infiltration of the joints
por: Rodgers, David T, et al.
Publicado: (2014)

The helminth product, ES-62 modulates dendritic cell responses by inducing the selective autophagolysosomal degradation of TLR-transducers, as exemplified by PKCδ
por: Eason, Russell J., et al.
Publicado: (2016)

Lessons from helminth infections: ES-62 highlights new interventional approaches in rheumatoid arthritis
por: Pineda, M A, et al.
Publicado: (2014)

Mast Cell Subsets and Their Functional Modulation by the Acanthocheilonema viteae Product ES-62
por: Ball, Dimity H., et al.
Publicado: (2013)

ES‐62 Protects Against Collagen‐Induced Arthritis by Resetting Interleukin‐22 Toward Resolution of Inflammation in the Joints
por: Pineda, Miguel A., et al.
Publicado: (2014)

The Carbohydrate-linked Phosphorylcholine of the Parasitic Nematode Product ES-62 Modulates Complement Activation
por: Ahmed, Umul Kulthum, et al.
Publicado: (2016)

A novel therapeutic approach to cytokine modulation in articular inflammation using filarial nematode derived ES-62
por: McInnes, IB, et al.
Publicado: (2003)

The helminth product, ES-62, protects against airway inflammation by resetting the Th cell phenotype
por: Rzepecka, Justyna, et al.
Publicado: (2013)

Apicomplexan autophagy and modulation of autophagy in parasite-infected host cells
por: Latré de Laté, Perle, et al.
Publicado: (2017)

Allergy and Parasites
por: Bruschi, Fabrizio, et al.
Publicado: (2013)

Brugia malayi Antigen (BmA) Inhibits HIV-1 Trans-Infection but Neither BmA nor ES-62 Alter HIV-1 Infectivity of DC Induced CD4(+) Th-Cells
por: Mouser, Emily E. I. M., et al.
Publicado: (2016)

Parasitic worms and inflammatory diseases
por: ZACCONE, P, et al.
Publicado: (2006)

Synaptic amplification by dendritic spines enhances input cooperativity
por: Harnett, Mark T., et al.
Publicado: (2012)

The circadian regulator BMAL1 programmes responses to parasitic worm infection via a dendritic cell clock
por: Hopwood, Thomas W., et al.
Publicado: (2018)

Machine development SE 62 integer resonance with ES 43
por: Bleeker, J, et al.
Publicado: (1971)

Worms: Pernicious parasites or allies against allergies?
por: McSorley, Henry J., et al.
Publicado: (2018)

Vectorized instructive signals in cortical dendrites during a brain-computer interface task
por: Francioni, Valerio, et al.
Publicado: (2023)

Dendritic Guanidines as Efficient Analogues of Cell Penetrating Peptides
por: Bonduelle, Colin V., et al.
Publicado: (2010)

Opposing Somatic and Dendritic Expression of Stimulus-Selective Response Plasticity in Mouse Primary Visual Cortex
por: Kim, Taekeun, et al.
Publicado: (2020)

Novel Therapeutics for Multiple Sclerosis Designed by Parasitic Worms
por: Dixit, Aakanksha, et al.
Publicado: (2017)

Can CRISPR help in the fight against parasitic worms?
por: McVeigh, Paul, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i4glivcb2ubn18v0bad6ka44g6